Frontier Biotechnologies Inc. (SHA:688221)

Frontier Biotechnologies Statistics

Total Valuation

SHA:688221 has a market cap or net worth of CNY 6.47 billion. The enterprise value is 6.11 billion.

Market Cap	6.47B
Enterprise Value	6.11B

Important Dates

The next estimated earnings date is Saturday, August 30, 2025.

Earnings Date	Aug 30, 2025
Ex-Dividend Date	n/a

Share Statistics

SHA:688221 has 374.58 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	374.58M
Shares Outstanding	374.58M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-2.11%
Owned by Insiders (%)	16.08%
Owned by Institutions (%)	1.62%
Float	210.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	48.61
PB Ratio	5.90
P/TBV Ratio	6.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-32.18
EV / Sales	45.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-30.02

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.35.

Current Ratio	2.72
Quick Ratio	2.44
Debt / Equity	0.35
Debt / EBITDA	n/a
Debt / FCF	-1.87
Interest Coverage	-24.88

Financial Efficiency

Return on equity (ROE) is -15.92% and return on invested capital (ROIC) is -10.49%.

Return on Equity (ROE)	-15.92%
Return on Assets (ROA)	-8.70%
Return on Invested Capital (ROIC)	-10.49%
Return on Capital Employed (ROCE)	-20.26%
Revenue Per Employee	440,904
Profits Per Employee	-628,470
Employee Count	302
Asset Turnover	0.07
Inventory Turnover	1.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +247.65% in the last 52 weeks. The beta is 0.92, so SHA:688221's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	+247.65%
50-Day Moving Average	17.37
200-Day Moving Average	11.27
Relative Strength Index (RSI)	42.11
Average Volume (20 Days)	21,029,163

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688221 had revenue of CNY 133.15 million and -189.80 million in losses. Loss per share was -0.51.

Revenue	133.15M
Gross Profit	35.38M
Operating Income	-265.06M
Pretax Income	-189.80M
Net Income	-189.80M
EBITDA	-249.99M
EBIT	-265.06M
Loss Per Share	-0.51

Balance Sheet

The company has 746.10 million in cash and 381.05 million in debt, giving a net cash position of 365.04 million or 0.97 per share.

Cash & Cash Equivalents	746.10M
Total Debt	381.05M
Net Cash	365.04M
Net Cash Per Share	0.97
Equity (Book Value)	1.10B
Book Value Per Share	2.93
Working Capital	714.78M

Cash Flow

In the last 12 months, operating cash flow was -177.44 million and capital expenditures -26.04 million, giving a free cash flow of -203.48 million.

Operating Cash Flow	-177.44M
Capital Expenditures	-26.04M
Free Cash Flow	-203.48M
FCF Per Share	-0.54

Margins

Gross margin is 26.57%, with operating and profit margins of -199.06% and -142.54%.

Gross Margin	26.57%
Operating Margin	-199.06%
Pretax Margin	-142.54%
Profit Margin	-142.54%
EBITDA Margin	-187.75%
EBIT Margin	-199.06%
FCF Margin	n/a

Dividends & Yields

SHA:688221 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	n/a
Earnings Yield	-2.93%
FCF Yield	-3.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688221 has an Altman Z-Score of 1.03 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.03
Piotroski F-Score	3